BioGeneration Ventures
Rianne Ellenbroek joined BGV in 2020 as Investment Manager of the Fonds InvesteringsRijpe Starters (FIRST) fund. Prior to joining BGV, she was an Associate at INKEF Capital. Rianne is a medical biologist by training. She obtained her PhD at Leiden University that was focused on regenerative medicine for metabolic diseases, while performing part of her activities at biotech company Galapagos. Winning a grant facilitated her to take a position as postdoctoral fellow at the Kovler Diabetes Center at the University of Chicago. Next to performing her research, she was a fellow at the university’s Technology Transfer Office which has sparked her interest in the early stages of life sciences ventures.
This person is not in any offices
BioGeneration Ventures
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.